Find Sucralfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

0

South Africa

FDF DossiersDRUG PRODUCT COMPOSITIONS

107RELATED EXCIPIENT COMPANIES

175EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Gtpl7055, Q420394, [({[(2s,3r,4s,5r,6r)-4,5-bis({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-6-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]-2-{[(2r,3s,4s,5r)-3,4,5-tris({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-2-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]oxolan-2-yl]oxy}oxan-3-yl]oxy}sulfonyl)oxy]alumanediol
Molecular Formula
C11H44Al8O51S8
Molecular Weight
1464.8  g/mol
InChI Key
FTFYNJYNMCKWAJ-JQOFMKNESA-F

Sucralfate
1 2D Structure

Sucralfate

2 Identification
2.1 Computed Descriptors
2.1.1 InChI
InChI=1S/C11H20O35S8.8Al.16H2O/c12-47(13,14)36-1-3-4(41-49(18,19)20)5(42-50(21,22)23)6(43-51(24,25)26)9(38-3)39-11(2-37-48(15,16)17)8(45-53(30,31)32)7(44-52(27,28)29)10(40-11)46-54(33,34)35;;;;;;;;;;;;;;;;;;;;;;;;/h3-10H,1-2H2,(H,12,13,14)(H,15,16,17)(H,18,19,20)(H,21,22,23)(H,24,25,26)(H,27,28,29)(H,30,31,32)(H,33,34,35);;;;;;;;;16*1H2/q;8*+1;;;;;;;;;;;;;;;;/p-8/t3-,4-,5+,6-,7+,8+,9+,10-,11-;;;;;;;;;;;;;;;;;;;;;;;;/m1......................../s1
2.1.2 InChI Key
FTFYNJYNMCKWAJ-JQOFMKNESA-F
2.1.3 Canonical SMILES
C(C1C(C(C(C(O1)OC2(C(C(C(O2)OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O
2.1.4 Isomeric SMILES
C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Gtpl7055

2. Q420394

3. [({[(2s,3r,4s,5r,6r)-4,5-bis({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-6-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]-2-{[(2r,3s,4s,5r)-3,4,5-tris({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-2-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]oxolan-2-yl]oxy}oxan-3-yl]oxy}sulfonyl)oxy]alumanediol

2.3 Create Date
2013-03-06
3 Chemical and Physical Properties
Molecular Weight 1464.8 g/mol
Molecular Formula C11H44Al8O51S8
Hydrogen Bond Donor Count16
Hydrogen Bond Acceptor Count51
Rotatable Bond Count36
Exact Mass1463.713824 g/mol
Monoisotopic Mass1463.713824 g/mol
Topological Polar Surface Area532 Ų
Heavy Atom Count78
Formal Charge0
Complexity2400
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count17
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameCarafate
PubMed HealthSucralfate (By mouth)
Drug ClassesAntiulcer, Protectant
Drug LabelCARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus...
Active IngredientSucralfate
Dosage FormTablet; Suspension
RouteOral
Strength1gm/10ml; 1gm
Market StatusPrescription
CompanyForest Labs

2 of 2  
Drug NameCarafate
PubMed HealthSucralfate (By mouth)
Drug ClassesAntiulcer, Protectant
Drug LabelCARAFATE Suspension contains sucralfate and sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.CARAFATE Suspension for oral administration contains 1 g of sucralfate per 10 mL.CARAFATE Sus...
Active IngredientSucralfate
Dosage FormTablet; Suspension
RouteOral
Strength1gm/10ml; 1gm
Market StatusPrescription
CompanyForest Labs

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 42641

Submission : 2025-09-23

Status : Active

Type : II

Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38867

Submission : 2023-09-13

Status : Active

Type : II

Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothArchimica: Excellence in complex chemical technologies, regulatory-approved manufacturing, and API innovation.

Flag Italy
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2014-04-18

Pay. Date : 2014-04-09

DMF Number : 16589

Submission : 2003-05-13

Status : Active

Type : II

CB

04

Ace Japan Co Ltd

Japan

USDMF

arrow
PEGS Boston Summit
Not Confirmed

04

05

PEGS Boston Summit
Not Confirmed

05

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3542

Submission : 1979-06-12

Status : Active

Type : II

blank

06

Nippon Kayaku Co Ltd

Japan

USDMF

arrow
PEGS Boston Summit
Not Confirmed

06

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 6048

Submission : 1985-09-27

Status : Inactive

Type : II

blank

07

PEGS Boston Summit
Not Confirmed

08

Orgamol Sa

Switzerland

USDMF

arrow
PEGS Boston Summit
Not Confirmed

08

Orgamol Sa

Switzerland
arrow
PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5825

Submission : 1985-05-14

Status : Inactive

Type : II

blank

09

PEGS Boston Summit
Not Confirmed

09

PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 6331

Submission : 1985-10-25

Status : Inactive

Type : II

blank

10

Shanghai No 6 Pharmaceutical Factory

Country

USDMF

arrow
PEGS Boston Summit
Not Confirmed

10

Shanghai No 6 Pharmaceutical Factory

Country
arrow
PEGS Boston Summit
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 6057

Submission : 1985-09-05

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more

01

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Certificate Number : CEP 2024-342 - Rev 00

Status : Valid

Issue Date : 2025-12-10

Type : Chemical

Substance Number : 1796

blank

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Certificate Number : CEP 2019-185 - Rev 02

Status : Valid

Issue Date : 2025-10-30

Type : Chemical

Substance Number : 1796

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

SNJ Labs

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.

Flag India
Digital Content Digital Content

Sucralfate USP

Date of Issue : 2026-01-01

Valid Till : 2028-10-21

Written Confirmation Number : WC-0454

Address of the Firm : Plot No. 5 to 16, Survey No. 137, At & Post: Padavala, Ta-Kotda Sangani, Dist.-R...

Company Banner

02

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sucralfate USP

Date of Issue : 2023-11-28

Valid Till : 2026-11-28

Written Confirmation Number : WC-0310

Address of the Firm : Plot No. Z-103/l, Dahej SEZ, Phase II, Dahej, Dist-Bharuch, Gujarat, India

blank

03

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sucralfate USP/EP

Date of Issue : 2026-03-16

Valid Till : 2029-03-15

Written Confirmation Number : WC-0457

Address of the Firm : Sy No 544, 545 & 546, Bhiknoor (V), Bhiknoor (M), Kamareddy-503101, Telangana, I...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

SNJ Labs

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSNJ Labs: WHO-GMP certified API leader in India, specializing in bulk drugs & intermediates with unmatched expertise.

Flag India
Digital Content Digital Content

Sucralfate

About the Company : SNJ Labs Pvt. Ltd., established in 2013, is India’s largest manufacturer of Iron Sucrose, achieving a production capacity of 120 MT per year within five years. The company specia...

SNJ Labs Pvt. Ltd., established in 2013, is India’s largest manufacturer of Iron Sucrose, achieving a production capacity of 120 MT per year within five years. The company specializes in APIs and intermediates, including Alpha Ketoanalogues Calcium/Magnesium Salts and Ferric Carboxymaltose. Driven by strong product quality, an experienced doctorate-led management team, & global and domestic partnerships, SNJ Labs operates from advanced facilities in Rajkot, delivering consistent and reliable pharmaceutical solutions worldwide. Note:Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPI Health Sciences: Biotech for Hire providing end-to-end discovery and development powered by chemistry, biology, and AI.

Flag India
Digital Content Digital Content

Sucralfate

About the Company : PI Health Sciences offers end-to-end drug discovery and development, integrating medicinal chemistry, synthetic chemistry, biology, and AI-driven technologies. Its co-located teams...

PI Health Sciences offers end-to-end drug discovery and development, integrating medicinal chemistry, synthetic chemistry, biology, and AI-driven technologies. Its co-located teams and flexible models accelerate candidate optimization to IND readiness. With expertise in complex chemistries, process R&D, and scalable API/HPAPI manufacturing in India and Italy, PI Health Sciences ensures quality, reliability, and global compliance, partnering with pharma and biotech for fast, precise innovation. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

03

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Sucralfate

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Flag U.S.A
Digital Content Digital Content

Sucralfate

About the Company : Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered i...

Rochem, established in 1994, is a global distributor of pharmaceutical, food, nutritional, and animal health ingredients, sourcing high-quality products from China. Headquartered in Hauppauge, New York, it operates 16 offices worldwide. Rochem’s operations are fully cGMP compliant and have been audited by the USFDA and several multinational organizations. The company also trains and audits its partners to ensure FDA-compliant technologies and systems. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Rochem

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWillow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

Flag U.S.A
Digital Content Digital Content

Sucralfate

About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...

Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 states as a drug wholesaler and NABP accreditation since 2007, Willow Birch Pharma delivers top-quality products at competitive prices with unparalleled service and regulatory support nationwide. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Company Banner

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sucralfate

About the Company : Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Indus...

Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Industries all over the world for the past 10 years with good track regard of keeping our customers happy. We are specialized in the area of Vitamins, Nutraceuticals and Excipients. Our main products are N-Acetyl-L-Cysteine, Pyridoxine Hydrochloride, Thiamine Hydrochloride and Benfotiamine. The company growth is mainly driven by technology based research and development to meet customer demands.
blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sucralfate

About the Company : Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent ...

Aspire group was established in the year 2000 with a motto of quality drug for better health of all. In its journey till date, aspire has developed enormous reputation, consistent growth, unique technologies and world class quality healthcare products. Aspire is pioneer in manufacturing and sourcing unique healthcare products. True to the statement, “Where the future started yesterday” with a foresight on the current trends in the healthcare market, Aspire has grown from strength combining its research strength, Human resources and well established quality systems. Aspire has crossed numerous milestones in a comparatively short period since its inception.
blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sucralfate

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

09

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sucralfate

About the Company : Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing p...

Consistent growth and sustainability is a multidimensional aspiration for all at Macleods, we remained focused on providing quality and affordable medicines to billions of ailing patients across geographies and bridging the gap of unmet needs of medical fraternity through continuous innovation. Our basic business philosophy, by its very nature, serves a social responsibility hence we have a far better reason than profits alone to drive our performance. Sustainability, is not a trend we blindly follow, it is intrinsic to how we have operated since the genesis of the organization in the year 1986.
blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Sucralfate

About the Company : Northeast Pharmaceutical Group Co., Ltd ( NEPG ) is a large-scale comprehensive pharmaceutical enterprise in China.It is composed of three major business segments, i.e. 1. chemical...

Northeast Pharmaceutical Group Co., Ltd ( NEPG ) is a large-scale comprehensive pharmaceutical enterprise in China.It is composed of three major business segments, i.e. 1. chemical synthetic API and bio-fermentation API, 2. western medicinal preparation and micro-ecological preparation, 3. medical business distribution. NEPG produces 12 major series, mainly covering Vitamin Series, Antibiotics, Anti-AIDS, Digestives, Narcotic medicines, Cardiovascular and Cerebrovascular medicines, etc. NEPG is proud of being the first Vitamin C producer in China,
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 1GM

USFDA APPLICATION NUMBER - 18333

read-more

DOSAGE - SUSPENSION;ORAL - 1GM/10ML

USFDA APPLICATION NUMBER - 19183

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Co-Processed Excipients

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Granulation

read-more
read-more

Lubricants & Glidants

read-more
read-more

Taste Masking

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Parenteral

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Coating Systems & Additives

read-more
read-more

Solubilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Emulsifying Agents

read-more
read-more

Topical

read-more
read-more

Soft Gelatin

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Looking for / Sucralfate API manufacturers, exporters & distributors?

Sucralfate manufacturers, exporters & distributors 1

53

PharmaCompass offers a list of Sucralfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sucralfate manufacturer or Sucralfate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sucralfate manufacturer or Sucralfate supplier.

API | Excipient name

Sucralfate

Synonyms

Gtpl7055, Q420394, [({[(2s,3r,4s,5r,6r)-4,5-bis({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-6-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]-2-{[(2r,3s,4s,5r)-3,4,5-tris({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)-2-[({[(dihydroxyalumanyl)oxy]sulfonyl}oxy)methyl]oxolan-2-yl]oxy}oxan-3-yl]oxy}sulfonyl)oxy]alumanediol

Sucramal Manufacturers

A Sucramal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sucramal, including repackagers and relabelers. The FDA regulates Sucramal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sucramal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Sucramal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Sucramal Suppliers

A Sucramal supplier is an individual or a company that provides Sucramal active pharmaceutical ingredient (API) or Sucramal finished formulations upon request. The Sucramal suppliers may include Sucramal API manufacturers, exporters, distributors and traders.

click here to find a list of Sucramal suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Sucramal USDMF

A Sucramal DMF (Drug Master File) is a document detailing the whole manufacturing process of Sucramal active pharmaceutical ingredient (API) in detail. Different forms of Sucramal DMFs exist exist since differing nations have different regulations, such as Sucramal USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Sucramal DMF submitted to regulatory agencies in the US is known as a USDMF. Sucramal USDMF includes data on Sucramal's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sucramal USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Sucramal suppliers with USDMF on PharmaCompass.

Sucramal JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Sucramal Drug Master File in Japan (Sucramal JDMF) empowers Sucramal API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Sucramal JDMF during the approval evaluation for pharmaceutical products. At the time of Sucramal JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Sucramal suppliers with JDMF on PharmaCompass.

Sucramal KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Sucramal Drug Master File in Korea (Sucramal KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Sucramal. The MFDS reviews the Sucramal KDMF as part of the drug registration process and uses the information provided in the Sucramal KDMF to evaluate the safety and efficacy of the drug.

After submitting a Sucramal KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Sucramal API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Sucramal suppliers with KDMF on PharmaCompass.

Sucramal CEP

A Sucramal CEP of the European Pharmacopoeia monograph is often referred to as a Sucramal Certificate of Suitability (COS). The purpose of a Sucramal CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sucramal EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sucramal to their clients by showing that a Sucramal CEP has been issued for it. The manufacturer submits a Sucramal CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sucramal CEP holder for the record. Additionally, the data presented in the Sucramal CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sucramal DMF.

A Sucramal CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sucramal CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Sucramal suppliers with CEP (COS) on PharmaCompass.

Sucramal WC

A Sucramal written confirmation (Sucramal WC) is an official document issued by a regulatory agency to a Sucramal manufacturer, verifying that the manufacturing facility of a Sucramal active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Sucramal APIs or Sucramal finished pharmaceutical products to another nation, regulatory agencies frequently require a Sucramal WC (written confirmation) as part of the regulatory process.

click here to find a list of Sucramal suppliers with Written Confirmation (WC) on PharmaCompass.

Sucramal NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sucramal as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Sucramal API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Sucramal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Sucramal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sucramal NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Sucramal suppliers with NDC on PharmaCompass.

Sucramal GMP

Sucramal Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Sucramal GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Sucramal GMP manufacturer or Sucramal GMP API supplier for your needs.

Sucramal CoA

A Sucramal CoA (Certificate of Analysis) is a formal document that attests to Sucramal's compliance with Sucramal specifications and serves as a tool for batch-level quality control.

Sucramal CoA mostly includes findings from lab analyses of a specific batch. For each Sucramal CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Sucramal may be tested according to a variety of international standards, such as European Pharmacopoeia (Sucramal EP), Sucramal JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sucramal USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty